Cargando…

Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies

BACKGROUND: Cervical dystonia is a heterogeneous disorder with several possible presentations, for which first-line therapy is often botulinum toxin (BoNT). In routine clinical practice the success of each BoNT injection is dependent on several variables, including individual presentation and inject...

Descripción completa

Detalles Bibliográficos
Autores principales: Misra, Vijay P., Trosch, Richard M., Maisonobe, Pascal, Om, Savary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036690/
https://www.ncbi.nlm.nih.gov/pubmed/30002865
http://dx.doi.org/10.1186/s40734-018-0072-8
_version_ 1783338200278761472
author Misra, Vijay P.
Trosch, Richard M.
Maisonobe, Pascal
Om, Savary
author_facet Misra, Vijay P.
Trosch, Richard M.
Maisonobe, Pascal
Om, Savary
author_sort Misra, Vijay P.
collection PubMed
description BACKGROUND: Cervical dystonia is a heterogeneous disorder with several possible presentations, for which first-line therapy is often botulinum toxin (BoNT). In routine clinical practice the success of each BoNT injection is dependent on several variables, including individual presentation and injection technique. Large multicenter, observational studies provide important information on individualized administration strategies that cannot be otherwise ascertained from controlled clinical trials. In this meta-analysis of patient level data, we aimed to evaluate the clinical characteristics of patients with cervical dystonia undergoing routine treatment with botulinum toxin, specifically abobotulinumtoxinA. We also aimed to characterize current abobotulinumtoxinA injection techniques and parameters and to explore international differences in patient presentation and treatment. METHODS: This was a meta-analysis of baseline data from three prospective, international, multicenter, observational studies (NCT01314365, NCT00833196 and NCT01753349) of botulinum toxin treatment for the routine management of adult cervical dystonia. RESULTS: Data presented illustrate the significant heterogeneity of CD presentation in routine practice. Most subjects presented with a complex pattern of dystonic movements and the majority had additional components of shoulder elevation, tremor and/or jerk. Dosing was generally in accordance with that recommended in the abobotulinumtoxinA prescribing information, although the range of dosing also indicates that injections are tailored to individual presentation. Sub-group analyses at the country level revealed distinct differences in injection practice. CONCLUSIONS: This meta-analysis is based on the largest dataset of subjects with cervical dystonia studied to date. The heterogeneity revealed in our baseline findings support the need to develop consistent, practical and comprehensive best practice guidelines.
format Online
Article
Text
id pubmed-6036690
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60366902018-07-12 Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies Misra, Vijay P. Trosch, Richard M. Maisonobe, Pascal Om, Savary J Clin Mov Disord Research Article BACKGROUND: Cervical dystonia is a heterogeneous disorder with several possible presentations, for which first-line therapy is often botulinum toxin (BoNT). In routine clinical practice the success of each BoNT injection is dependent on several variables, including individual presentation and injection technique. Large multicenter, observational studies provide important information on individualized administration strategies that cannot be otherwise ascertained from controlled clinical trials. In this meta-analysis of patient level data, we aimed to evaluate the clinical characteristics of patients with cervical dystonia undergoing routine treatment with botulinum toxin, specifically abobotulinumtoxinA. We also aimed to characterize current abobotulinumtoxinA injection techniques and parameters and to explore international differences in patient presentation and treatment. METHODS: This was a meta-analysis of baseline data from three prospective, international, multicenter, observational studies (NCT01314365, NCT00833196 and NCT01753349) of botulinum toxin treatment for the routine management of adult cervical dystonia. RESULTS: Data presented illustrate the significant heterogeneity of CD presentation in routine practice. Most subjects presented with a complex pattern of dystonic movements and the majority had additional components of shoulder elevation, tremor and/or jerk. Dosing was generally in accordance with that recommended in the abobotulinumtoxinA prescribing information, although the range of dosing also indicates that injections are tailored to individual presentation. Sub-group analyses at the country level revealed distinct differences in injection practice. CONCLUSIONS: This meta-analysis is based on the largest dataset of subjects with cervical dystonia studied to date. The heterogeneity revealed in our baseline findings support the need to develop consistent, practical and comprehensive best practice guidelines. BioMed Central 2018-07-09 /pmc/articles/PMC6036690/ /pubmed/30002865 http://dx.doi.org/10.1186/s40734-018-0072-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Misra, Vijay P.
Trosch, Richard M.
Maisonobe, Pascal
Om, Savary
Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
title Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
title_full Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
title_fullStr Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
title_full_unstemmed Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
title_short Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
title_sort spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxina: findings from three prospective open-label observational studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036690/
https://www.ncbi.nlm.nih.gov/pubmed/30002865
http://dx.doi.org/10.1186/s40734-018-0072-8
work_keys_str_mv AT misravijayp spectrumofpracticeintheroutinemanagementofcervicaldystoniawithabobotulinumtoxinafindingsfromthreeprospectiveopenlabelobservationalstudies
AT troschrichardm spectrumofpracticeintheroutinemanagementofcervicaldystoniawithabobotulinumtoxinafindingsfromthreeprospectiveopenlabelobservationalstudies
AT maisonobepascal spectrumofpracticeintheroutinemanagementofcervicaldystoniawithabobotulinumtoxinafindingsfromthreeprospectiveopenlabelobservationalstudies
AT omsavary spectrumofpracticeintheroutinemanagementofcervicaldystoniawithabobotulinumtoxinafindingsfromthreeprospectiveopenlabelobservationalstudies